Based on the key indicators related to Tff Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Tff Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December. At this time, Tff Pharmaceuticals' Property Plant And Equipment Net is relatively stable compared to the past year. As of 11/27/2024, Property Plant And Equipment Gross is likely to grow to about 2.3 M, while Accounts Payable is likely to drop slightly above 759.2 K. Key indicators impacting Tff Pharmaceuticals' financial strength include:
The essential information of the day-to-day investment outlook for Tff Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Tff Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Tff Pharmaceuticals.
Net Income
(22.31 Million)
Tff
Select Account or Indicator
Market Cap
Enterprise Value
Ptb Ratio
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Pb Ratio
Free Cash Flow Per Share
Roic
Net Income Per Share
Cash Per Share
Pocfratio
Capex To Operating Cash Flow
Pfcf Ratio
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Graham Number
Shareholders Equity Per Share
Capex Per Share
Graham Net Net
Enterprise Value Over E B I T D A
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Ebt Per Ebit
Effective Tax Rate
Company Equity Multiplier
Return On Capital Employed
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Cash Ratio
Free Cash Flow Operating Cash Flow Ratio
Price To Book Ratio
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Return On Assets
Price Fair Value
Return On Equity
Change In Cash
Other Cashflows From Financing Activities
Capital Expenditures
Total Cash From Operating Activities
Change To Operating Activities
Net Income
Total Cash From Financing Activities
Change To Netincome
Change To Liabilities
Investments
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
End Period Cash Flow
Sale Purchase Of Stock
Stock Based Compensation
Other Non Cash Items
Issuance Of Capital Stock
Total Current Liabilities
Total Stockholder Equity
Net Tangible Assets
Retained Earnings
Accounts Payable
Total Liab
Total Assets
Cash
Non Current Assets Total
Non Currrent Assets Other
Common Stock Shares Outstanding
Non Current Liabilities Total
Net Invested Capital
Total Current Assets
Net Working Capital
Other Current Liab
Net Debt
Cash And Short Term Investments
Common Stock Total Equity
Liabilities And Stockholders Equity
Capital Surpluse
Other Current Assets
Other Stockholder Equity
Accumulated Other Comprehensive Income
Capital Stock
Common Stock
Property Plant And Equipment Net
Current Deferred Revenue
Property Plant And Equipment Gross
Interest Expense
Selling General Administrative
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Total Operating Expenses
Income Before Tax
Net Income Applicable To Common Shares
Net Interest Income
Interest Income
Other Operating Expenses
Ebitda
Total Other Income Expense Net
Income Tax Expense
Depreciation And Amortization
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Tff Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tff Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Tff Pharmaceuticals' assets may result in an increase in income on the income statement.
Tff Pharmaceuticals competes with Gain Therapeutics, In8bio, Lantern Pharma, INmune Bio, and Anebulo Pharmaceuticals. TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing technology platform in the United States and Australia. The company was incorporated in 2018 and is based in Austin, Texas. Tff Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Tff Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Tff Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tff Pharmaceuticals competition to find correlations between indicators driving Tff Pharmaceuticals's intrinsic value. More Info.
Tff Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Tff Pharmaceuticals' Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tff Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Tff Pharmaceuticals Systematic Risk
Tff Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tff Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Tff Pharmaceuticals correlated with the market. If Beta is less than 0 Tff Pharmaceuticals generally moves in the opposite direction as compared to the market. If Tff Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tff Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tff Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Tff Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Tff Pharmaceuticals Thematic Clasifications
Tff Pharmaceuticals is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
Today, most investors in Tff Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tff Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tff Pharmaceuticals growth as a starting point in their analysis.
Tff Pharmaceuticals November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tff Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tff Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tff Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Tff Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tff Pharmaceuticals's daily price indicators and compare them against related drivers.
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.